Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
34 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BIOPHARMATEK from Sint-Lambrechts-Woluwe, company number BE0675688340, closed financial year 2025 with a result of € 51,822 after tax. For that financial year BIOPHARMATEK recorded a gross margin of € 65,353 and equity of € 280,092. Compared with financial year 2024, the result moved from € 52,316 to € 51,822. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 280,092
▲ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 51,822
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 258,274
▲ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 259,632.
People and assets in 2025
€ 712
▼ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 68,443
▲ € 64,213 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,000
▼ 87% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 145,634 | € 127,847 | € 71,925 | € 65,353 | ▼ 9% |
| Profit after taxes | € 100,821 | € 69,644 | € 52,316 | € 51,822 | ▼ 1% |
| Equity | € 187,056 | € 256,701 | € 228,270 | € 280,092 | ▲ 23% |
| Total debts | € 774,274 | € 131,241 | € 186,318 | € 135,443 | ▼ 27% |
| Cash | € 37,759 | € 104,057 | € 169,118 | € 258,274 | ▲ 53% |
| Retained profit | € 168,456 | € 236,241 | € 207,810 | € 259,632 | ▲ 25% |
| Dividend | € 0 | € 0 | € 80,747 | € 0 | ▼ 100% |
| Balance sheet total | € 961,331 | € 387,942 | € 414,588 | € 415,535 |
Key figures of BIOPHARMATEK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOPHARMATEK?
What happened at BIOPHARMATEK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 51,822 (▼ 1% vs 2024). Source: NBB ↗
- New establishment in Watermaal-Bosvoorde. KBO
- Sudabeh AKBARZADEH-SHARBAH became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 100,821 profit in 2022 to € 51,822 profit in 2025.
Paid € 109,596 in corporate taxes since 2022.
Best year ever: 2022, with € 100,821 profit.
Paid out € 80,747 in dividends to the owners in total.
A new publication or filing at BIOPHARMATEK? We notify you, reason included.
Follow BIOPHARMATEKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BIOPHARMATEK is Sudabeh AKBARZADEH-SHARBAH.
Directors
According to the 2025 annual accounts
Sudabeh AKBARZADEH-SHARBAH
Director
since 2017
Establishments
Establishment units
Physical locations of this company
Veldkapelgaarde 30 box 1.30
1200 Sint-Lambrechts-Woluwe
Thujastraat 32
1170 Watermaal-Bosvoorde
Active since 12 May 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 34 companies are registered at this address.
All companies at this address →Centre de Sante Universitaire de la Faculte de Medecine de l'Universite Catholique de Louvain (Section francophone)
€ 28,963 revenue · 2024
Services de Santé Mentale de l'UCL à Bruxelles
€ 704 revenue · 2024
Belgische Vereniging voor Medische, Informatica - Société belge d'Informatique médicale
Centre universitaire d'information sur les Professions médicales et-ou paramédicales
European Society of Surgical Oncology
€ 1.2 million revenue · 2025
+29 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0675.688.340
- VAT number
- BE 0675.688.340
- Registered office
- Veldkapelgaarde 30 bus 1.30, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- BIOPHARMATEK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 May 2017
- Peppol
- Active · Active since 5 Nov 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in andere specifieke goederen
Groothandel in informatie- en communicatieapparatuur
Groothandel in andere machines en werktuigen, neg
Groothandel in andere kantoormachines en kantoorbenodigdheden, met uitzondering van computers en randapparatuur
Groothandel in andere machines en werktuigen, n.e.g.